Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK-Reference-Cited by-同舟云学术

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK

Published:2017-06-08 Issue:8 Volume:20 Page:840-849
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Prabhu Vimalanand¹,Foo Jason²,Ahir Harblas³,Sarpong Eric¹,Merchant Sanjay¹

Affiliation:

1. Merck & Co., Inc., Kenilworth, NJ, USA;

2. Mapi Group, Houten, The Netherlands;

3. Merck Sharp & Dohme Limited, Hoddesdon, UK

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2017.1333960

Reference31 articles.

1. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study

2. Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

3. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review;BMJ Global Health;2024-02

2. Novel Classes of Antibacterial Drugs in Clinical Development, a Hope in a Post-antibiotic Era;Current Topics in Medicinal Chemistry;2018-10-10

3. Ceftolozane/tazobactam: place in therapy;Expert Review of Anti-infective Therapy;2018-03-09